Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin for Sterile Inflammation in Healthy Subjects
NCT03559868Phase 1Completed
- Sponsor
- Yale University
- Start
- Mar 2021
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of digoxin in sterile inflammation and steatohepatitis (3 arms), sponsored by Yale University. Primary endpoint: Spontaneous Reactive Oxygen Species Production at 3 weeks. Started Mar 2021; status: completed.
02
Drugs
digoxin
03
Conditions
sterile inflammationsteatohepatitis
Beyond the preview
Go deeper on NCT03559868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03559868.